Cavan, Pretty A.
HRN: 12-41-41 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/09/2023
CEFTRIAXONE 1G (VIAL)
10/09/2023
10/15/2023
IV
2gm
Q24
Urinary Tract Infection
Checking Final Appropriateness
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes